WallStreetZenWallStreetZen

NASDAQ: GEHC
Ge Healthcare Technologies Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

GEHC past earnings growth

How has GEHC's earnings growth performed historically?
Company
-26.79%
Industry
-4.28%
Market
72.61%
GEHC's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
GEHC's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance

GEHC past revenue growth

How has GEHC's revenue growth performed historically?
Company
6.6%
Industry
11.91%
Market
17.55%
GEHC's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
GEHC's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
GEHC's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

GEHC earnings and revenue history

Current Revenue
$19.6B
Current Earnings
$1.4B
Current Profit Margin
7.1%

GEHC Return on Equity

Current Company
19.7%
Current Industry
-0.2%
Current Market
188%
GEHC's Return on Equity (19.7%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when GEHC announces earnings.

GEHC Return on Assets

Current Company
4.3%
Current Industry
0.8%
GEHC is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

GEHC Return on Capital Employed

Current Company
12.15%
Current Industry
2.2%
GEHC's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

GEHC vs Health Information Service Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
GEHC$19.55B$3.46B$1.39B+4.13%-21.06%
VEEV$2.36B$632.34M$525.71M+22.35%+15.51%
HQY$999.59M$283.57M$55.71M+28.33%-11.54%
RCM$2.25B$437.70M$3.30M+21.02%-99.16%
DOCS$468.33M$186.53M$137.63M+21.63%-2.02%
View Top Health Information Service Stocks

Ge Healthcare Technologies Earnings & Revenue FAQ

What were GEHC's earnings last quarter?

On Invalid Date, Ge Healthcare Technologies (NASDAQ: GEHC) reported Q4 2023 earnings per share (EPS) of $0.89, up 26.45% year over year. Total Ge Healthcare Technologies earnings for the quarter were $403.00 million. In the same quarter last year, Ge Healthcare Technologies's earnings per share (EPS) was $1.21.

If you're new to stock investing, here's how to buy Ge Healthcare Technologies stock.

What was GEHC's earnings growth in the past year?

As of Q2 2024, Ge Healthcare Technologies's earnings has grown -26.79% year over year. This is 22.52 percentage points lower than the US Health Information Services industry earnings growth rate of -4.28%. Ge Healthcare Technologies's earnings in the past year totalled $1.39 billion.

What was GEHC's revenue last quarter?

On Invalid Date, Ge Healthcare Technologies (NASDAQ: GEHC) reported Q4 2023 revenue of $5.21 billion up 5.43% year over year. In the same quarter last year, Ge Healthcare Technologies's revenue was $4.94 billion.

What was GEHC's revenue growth in the past year?

As of Q2 2024, Ge Healthcare Technologies's revenue has grown 6.6% year over year. This is 5.31 percentage points lower than the US Health Information Services industry revenue growth rate of 11.91%. Ge Healthcare Technologies's revenue in the past year totalled $19.55 billion.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.